제품 수집
제품 세부정보
Synonyms
CEACAM6, CD66c, CEAL, NCA
Source
Human CEACAM-6, His Tag (CE6-H5223) is expressed from human 293 cells (HEK293). It contains AA Lys 35 - Gly 320 (Accession # P40199-1).
Predicted N-terminus: Lys 35
Request for sequenceMolecular Characterization
Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 32.03 kDa. The protein migrates as 45-65 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 0.01 EU per μg by the LAL method / rFC method.
Purity
>90% as determined by SDS-PAGE.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Shipping and Storage
This product is shipped at ambient temperature.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
고객님도 확인한 상품
데이터 표시
SDS-PAGE
Human CEACAM-6, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).
Bioactivity-ELISA
Immobilized Human CEACAM-6, His Tag (Cat. No. CE6-H5223) at 10 μg/mL (100 μL/well) can bind Biotinylated Human CEACAM-8, His,Avitag (Cat. No. CE8-H82E9) with a linear range of 0.02-0.313 μg/mL (QC tested).
Protocol
사용자 리뷰 댓글 남기기
FAQ
- Product
Are there any studies showing that CEACAM6 and CEACAM8 can interact?
Yes. According to the reference “Diverse oligomeric states of CEACAM IgV domains” (PNAS), CEACAMs can form homophilic and/or heterophilic interactions (e.g., CEACAM6–CEACAM8, CEACAM5–CEACAM6). Structural studies of the CEACAM6–CEACAM8 heterodimer showed that the addition of CEACAM8 to CEACAM6 led to heterodimer formation, confirming their ability to bind each other.
배경 소개
프론티어 진행
의약품 개발 진행- 영어 이름：
Carcinoembryonic antigen related cell adhesion molecule 6
- 카테고리：
- 상장 의약품 수：
0 상세
- 임상 의약품 수：
3 상세
- 최고 개발 단계：
Phase 2 Clinical
연락하기
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
신약 후보물질 라이선싱
